Mehmet Erdem Toker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mehmet Erdem Toker has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Cüneyt Arkan
Department of Cardiovascular Surgery, Koşuyolu High Training and Research Hospital, İstanbul, Türkiye
4 shared publications - Mehmet Balkanay
Department of Cardiovascular Surgery, İstanbul Yeni Yüzyıl University Faculty of Medicine, Gaziosmanpaşa Hospital, İstanbul, Türkiye
3 shared publications - Ömer Faruk Akardere
Department of Cardiovascular Surgery, Kartal Kosuyolu Heart Research and Training Hospital, Istanbul, Türkiye
3 shared publications Cevat Yakut
2 shared publicationsErcan Eren
2 shared publications- Fatih Yiğit
Department of Cardiovascular Surgery, University of Health Sciences, Koşuyolu High Specialization Education and Research Hospital, Istanbul, Türkiye
2 shared publications
Latest Publications
- Open Access
- 12 June 2026
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 29 (2) , 107-113
Short-term CentriMag® Support in INTERMACS 1–2 Cardiogenic Shock: Lessons from A Single-Center Experience
Objective: Acute cardiogenic shock (CS) developing in the setting of chronic heart failure is associated with high mortality and requires rapid hemodynamic intervention. This study aimed to evaluate the early outcomes of patients who received short-term mechanical circulatory support with the CentriMag® system for refractory CS and to assess the effectiveness of this strategy as a bridge therapy. Methods: This retrospective, single-center study included 30 consecutive patients who had been listed for heart transplantation and underwent CentriMag® short-term ventricular assist device (VAD) implantation due to the development of CS between September 2010 and December 2013 in our hospital. CS was defined as persistent low cardiac output despite inotropic therapy and intra-aortic balloon pump support. The primary endpoints were survival to hospital discharge and successful bridging to recovery, durable support, or heart transplantation. Secondary endpoints included hemodynamic and laboratory improvement as well as device-related complications. Results: The mean age of the patients was 32.7±15.2 years, and 70% were male. The mean left ventricular ejection fraction was 20.1%±4.0%. The most common etiologies of CS were idiopathic dilated cardiomyopathy (36.7%) and ischemic cardiomyopathy (26.7%). The most frequent post-operative complications were arrhythmia (36.6%), acute kidney injury (40%), and infection (33.3%). The mean duration of support was 33 days (range, 4–185). Eight patients (26.7%) were successfully bridged to heart transplantation and four (13.3%) to durable VAD support, while the 30-day survival rate was 60%. Conclusion: The CentriMag® short-term VAD provided effective hemodynamic stabilization, improved end-organ function, and enabled bridging to durable support or heart transplantation in a substantial proportion of patients with refractory CS. Despite the high complication rates inherent in this critically ill population, the survival outcomes were more favorable compared with conventional therapy. The CentriMag® system appears to be a reliable bridge-to-decision or bridge-to-transplant option for patients with advanced heart failure presenting with acute CS.
- 12 June 2026
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 29 (2) , 107-113
Open AccessShort-term CentriMag® Support in INTERMACS 1–2 Cardiogenic Shock: Lessons from A Single-Center Experience
Objective: Acute cardiogenic shock (CS) developing in the setting of chronic heart failure is associated with high mortality and requires rapid hemodynamic intervention. This study aimed to evaluate the early outcomes of patients who received short-term mechanical circulatory support with the CentriMag® system for refractory CS and to assess the effectiveness of this strategy as a bridge therapy. Methods: This retrospective, single-center study included 30 consecutive patients who had been listed for heart transplantation and underwent CentriMag® short-term ventricular assist device (VAD) implantation due to the development of CS between September 2010 and December 2013 in our hospital. CS was defined as persistent low cardiac output despite inotropic therapy and intra-aortic balloon pump support. The primary endpoints were survival to hospital discharge and successful bridging to recovery, durable support, or heart transplantation. Secondary endpoints included hemodynamic and laboratory improvement as well as device-related complications. Results: The mean age of the patients was 32.7±15.2 years, and 70% were male. The mean left ventricular ejection fraction was 20.1%±4.0%. The most common etiologies of CS were idiopathic dilated cardiomyopathy (36.7%) and ischemic cardiomyopathy (26.7%). The most frequent post-operative complications were arrhythmia (36.6%), acute kidney injury (40%), and infection (33.3%). The mean duration of support was 33 days (range, 4–185). Eight patients (26.7%) were successfully bridged to heart transplantation and four (13.3%) to durable VAD support, while the 30-day survival rate was 60%. Conclusion: The CentriMag® short-term VAD provided effective hemodynamic stabilization, improved end-organ function, and enabled bridging to durable support or heart transplantation in a substantial proportion of patients with refractory CS. Despite the high complication rates inherent in this critically ill population, the survival outcomes were more favorable compared with conventional therapy. The CentriMag® system appears to be a reliable bridge-to-decision or bridge-to-transplant option for patients with advanced heart failure presenting with acute CS.
- Open Access
- 1 March 2026
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 29 (1) , 26-33
Early Post-Operative Results of Patients Undergoing Coronary Endarterectomy in Addition to Coronary Artery Bypass Grafting Surgery
Objective: Coronary artery bypass grafting (CABG) operation maintains its importance as one of the most important treatment methods in the treatment of coronary artery disease (CAD). One of the main goals of this surgery is to achieve complete revascularization. CABG operation may be insufficient to provide complete revascularization in patients with diffuse CAD. In this case, coronary endarterectomy (CE) may be a treatment option. Our aim in our study is to investigate the post-operative early mortality and morbidity outcomes of patients who underwent CE in addition to CABG and the effect of CE on these results. Methods: Our study included 183 patients who underwent CE in addition to CABG surgery between January 01, 2017 and December 31, 2021. Patients with isolated CABG were included in our study and patients who underwent an additional procedure and redo surgeries were excluded from the study. The data of the patients were analyzed retrospectively, hospital database, archive records, and patient files were examined. Pre-operative, intraoperative, and post-operative data of the patients were examined. Results: The study was conducted with a total of 183 subjects, 139 (76%) male and 44 (24%) female, whose ages ranged from 30 to 85. Early post-operative myocardial infarction was observed in 13.1% of the cases, and early mortality was observed in 8.7%. Conclusion: CE is an effective method to provide complete revascularization in patients with diffuse CAD, and it is a technique that should be applied in cases where there is no suitable area for anastomosis in the extensively diseased coronary artery.
- 1 March 2026
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 29 (1) , 26-33
Open AccessEarly Post-Operative Results of Patients Undergoing Coronary Endarterectomy in Addition to Coronary Artery Bypass Grafting Surgery
Objective: Coronary artery bypass grafting (CABG) operation maintains its importance as one of the most important treatment methods in the treatment of coronary artery disease (CAD). One of the main goals of this surgery is to achieve complete revascularization. CABG operation may be insufficient to provide complete revascularization in patients with diffuse CAD. In this case, coronary endarterectomy (CE) may be a treatment option. Our aim in our study is to investigate the post-operative early mortality and morbidity outcomes of patients who underwent CE in addition to CABG and the effect of CE on these results. Methods: Our study included 183 patients who underwent CE in addition to CABG surgery between January 01, 2017 and December 31, 2021. Patients with isolated CABG were included in our study and patients who underwent an additional procedure and redo surgeries were excluded from the study. The data of the patients were analyzed retrospectively, hospital database, archive records, and patient files were examined. Pre-operative, intraoperative, and post-operative data of the patients were examined. Results: The study was conducted with a total of 183 subjects, 139 (76%) male and 44 (24%) female, whose ages ranged from 30 to 85. Early post-operative myocardial infarction was observed in 13.1% of the cases, and early mortality was observed in 8.7%. Conclusion: CE is an effective method to provide complete revascularization in patients with diffuse CAD, and it is a technique that should be applied in cases where there is no suitable area for anastomosis in the extensively diseased coronary artery.
- Open Access
- 1 December 2025
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 28 (3) , 107-112
Off-pump or On-pump? Single-vessel Coronary Artery Bypass Grafting Surgery
Objectives: Off-pump coronary artery bypass grafting (OPCAB) was introduced to avoid the adverse effects of cardiopulmonary bypass used in on-pump coronary artery bypass grafting (ONCAB). While OPCAB is performed on a beating heart, often in a more challenging surgical field, ONCAB provides a stable, bloodless environment with the heart arrested. Despite extensive research comparing the two techniques, consensus on the optimal approach, particularly for single-vessel disease, remains unclear. Single-vessel disease accounts for approximately 3% of coronary bypass cases, with surgical intervention often preferred for proximal left anterior descending artery (LAD) lesions. Methods: A total of 336 patients aged 20–80 who underwent elective or emergency LAD bypass between 2015 and 2021 were included in the study. Patients were divided into OPCAB (n=125) and ONCAB (n=211) groups. Exclusion criteria included concomitant surgeries, prior cardiac surgery, endarterectomy, non-LAD single-vessel bypass, redo surgeries, hemodynamic instability, and severe arrhythmias. Pre-operative (age, gender, ejection fraction [EF], diabetes, chronic kidney disease), intraoperative (use of left internal mammary artery), and post-operative outcomes (drainage, transfusions, complications, intensive care unit (ICU)/hospital stay, 30- day mortality) were analyzed. Emergency cases included unstable angina or myocardial infarction, while elective cases involved stable coronary disease. Results: Results indicated that the OPCAB group had older patients with lower EFs. There were no significant differences in post-operative complications or mortality rates between the two groups, although OPCAB patients experienced shorter ICU and hospital stays. Importantly, OPCAB demonstrated comparable effectiveness to ONCAB, particularly in older patients and those with lower EFs. Factors influencing mortality included new-onset cerebrovascular accidents and acute renal failure. Conclusion: This study contributes to the limited literature on single-vessel disease and suggests that OPCAB should be considered the first choice in suitable patients due to its reliability and potential benefits. Further research is encouraged to explore these findings in a broader context.
- 1 December 2025
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 28 (3) , 107-112
Open AccessOff-pump or On-pump? Single-vessel Coronary Artery Bypass Grafting Surgery
Objectives: Off-pump coronary artery bypass grafting (OPCAB) was introduced to avoid the adverse effects of cardiopulmonary bypass used in on-pump coronary artery bypass grafting (ONCAB). While OPCAB is performed on a beating heart, often in a more challenging surgical field, ONCAB provides a stable, bloodless environment with the heart arrested. Despite extensive research comparing the two techniques, consensus on the optimal approach, particularly for single-vessel disease, remains unclear. Single-vessel disease accounts for approximately 3% of coronary bypass cases, with surgical intervention often preferred for proximal left anterior descending artery (LAD) lesions. Methods: A total of 336 patients aged 20–80 who underwent elective or emergency LAD bypass between 2015 and 2021 were included in the study. Patients were divided into OPCAB (n=125) and ONCAB (n=211) groups. Exclusion criteria included concomitant surgeries, prior cardiac surgery, endarterectomy, non-LAD single-vessel bypass, redo surgeries, hemodynamic instability, and severe arrhythmias. Pre-operative (age, gender, ejection fraction [EF], diabetes, chronic kidney disease), intraoperative (use of left internal mammary artery), and post-operative outcomes (drainage, transfusions, complications, intensive care unit (ICU)/hospital stay, 30- day mortality) were analyzed. Emergency cases included unstable angina or myocardial infarction, while elective cases involved stable coronary disease. Results: Results indicated that the OPCAB group had older patients with lower EFs. There were no significant differences in post-operative complications or mortality rates between the two groups, although OPCAB patients experienced shorter ICU and hospital stays. Importantly, OPCAB demonstrated comparable effectiveness to ONCAB, particularly in older patients and those with lower EFs. Factors influencing mortality included new-onset cerebrovascular accidents and acute renal failure. Conclusion: This study contributes to the limited literature on single-vessel disease and suggests that OPCAB should be considered the first choice in suitable patients due to its reliability and potential benefits. Further research is encouraged to explore these findings in a broader context.
- Open Access
- 13 October 2025
- Published by IMR Press in The Heart Surgery Forum
- Vol. 28 (10)
Long-Term Results of Transseptal Atriotomy in Small Left Atrium
Background: Transseptal atriotomy provides better exposure to the mitral valve in challenging cases but has conflicting results with postoperative rhythm disturbances. We aimed to investigate long term results of limited transseptal atriotomy in cases with a small left atrium. Methods: From January 2010 through February 2014, 1214 patients underwent mitral valve surgery at the SBÜ Kartal Kosuyolu High Specialization Training and Research Hospital. Left atrium diameter on 2-dimensional (2-D) echocardiography defined in 119 patients who had small left atrium and met the inclusion criteria were enrolled in the study, of which 57 patients (47.9%) underwent transseptal atriotomy (Group TS), while 62 patients (52.1%) underwent a left atriotomy (Group LA). Data was retrospectively collected. Long-term analyses were performed based on survival. The mean follow-up duration was 10.7 ± 4.2 years. Results: Isolated mitral procedures were performed in 49 patients (41.2%). Concomitant tricuspid valve surgery was performed in 42 patients (35.3%), concomitant aortic valve surgery in 24 patients (20.2%), and concomitant coronary artery bypass grafting in 15 patients (12.6%). The procedure rates were comparable in both Groups (p > 0.05). There was no significant difference in pre-operative variables. Ischemic time and total perfusion time were found to be similar in the Group TS vs. Group LA (87.6 ± 33.5 vs. 77.4 ± 27.8 minutes and 117.2 ± 38.4 vs. 112.3 ± 33.8 minutes respectively; p > 0.05). New-onset arrhythmia was higher in the Group TS but did not reach statistical significance (26.3% vs. 19.4%; p = 0.5). The rate of permanent pacemaker insertion was similar (5.3% vs. 4.8%; p = 0.9). Follow-up was completed in all cases and survival rate was 64.7% (64 ± 7% in Group TS vs. 58 ± 7% in Group LA; p > 0.05). Log rank analyses shows similar survivals (Group TS: 11.7 ± 0.6 years, 95% CI: 10.5–12.9; Group LA: 11.8 ± 0.6 years, 95% CI: 10.6–12.9; p > 0.05). In the multivariate Cox regression analysis, age, obesity, procedure type, and left ventricular dysfunction were found to be independent risk factors for late mortality. Regardless of tricuspid valve surgery, concomitant coronary artery bypass grafting (CABG) had worse survival compared to isolated mitral procedures and concomitant aortic valve replacement (AVR) (12.5 ± 0.5 years for mitral, 11.4 ± 1 years for concomitant AVR, and 8.2 ± 1.2 years for concomitant CABG; p < 0.01). Conclusion: Limited transseptal atriotomy was not found to be inferior when compared to left atriotomy in cases with a small left atrium undergoing while mitral valve (MV) should be performed when the exposure is challenging.
- 13 October 2025
- Published by IMR Press in The Heart Surgery Forum
- Vol. 28 (10)
Open AccessLong-Term Results of Transseptal Atriotomy in Small Left Atrium
Background: Transseptal atriotomy provides better exposure to the mitral valve in challenging cases but has conflicting results with postoperative rhythm disturbances. We aimed to investigate long term results of limited transseptal atriotomy in cases with a small left atrium. Methods: From January 2010 through February 2014, 1214 patients underwent mitral valve surgery at the SBÜ Kartal Kosuyolu High Specialization Training and Research Hospital. Left atrium diameter on 2-dimensional (2-D) echocardiography defined in 119 patients who had small left atrium and met the inclusion criteria were enrolled in the study, of which 57 patients (47.9%) underwent transseptal atriotomy (Group TS), while 62 patients (52.1%) underwent a left atriotomy (Group LA). Data was retrospectively collected. Long-term analyses were performed based on survival. The mean follow-up duration was 10.7 ± 4.2 years. Results: Isolated mitral procedures were performed in 49 patients (41.2%). Concomitant tricuspid valve surgery was performed in 42 patients (35.3%), concomitant aortic valve surgery in 24 patients (20.2%), and concomitant coronary artery bypass grafting in 15 patients (12.6%). The procedure rates were comparable in both Groups (p > 0.05). There was no significant difference in pre-operative variables. Ischemic time and total perfusion time were found to be similar in the Group TS vs. Group LA (87.6 ± 33.5 vs. 77.4 ± 27.8 minutes and 117.2 ± 38.4 vs. 112.3 ± 33.8 minutes respectively; p > 0.05). New-onset arrhythmia was higher in the Group TS but did not reach statistical significance (26.3% vs. 19.4%; p = 0.5). The rate of permanent pacemaker insertion was similar (5.3% vs. 4.8%; p = 0.9). Follow-up was completed in all cases and survival rate was 64.7% (64 ± 7% in Group TS vs. 58 ± 7% in Group LA; p > 0.05). Log rank analyses shows similar survivals (Group TS: 11.7 ± 0.6 years, 95% CI: 10.5–12.9; Group LA: 11.8 ± 0.6 years, 95% CI: 10.6–12.9; p > 0.05). In the multivariate Cox regression analysis, age, obesity, procedure type, and left ventricular dysfunction were found to be independent risk factors for late mortality. Regardless of tricuspid valve surgery, concomitant coronary artery bypass grafting (CABG) had worse survival compared to isolated mitral procedures and concomitant aortic valve replacement (AVR) (12.5 ± 0.5 years for mitral, 11.4 ± 1 years for concomitant AVR, and 8.2 ± 1.2 years for concomitant CABG; p < 0.01). Conclusion: Limited transseptal atriotomy was not found to be inferior when compared to left atriotomy in cases with a small left atrium undergoing while mitral valve (MV) should be performed when the exposure is challenging.
- Open Access
- 1 December 2024
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 27 (3) , 119-125
A Comparison of Early and Medium-term Results of De Vega Annuloplasty and Ring Annuloplasty Techniques for the Tricuspid Valve Repair in Patients Undergoing Mitral Valve Replacement
Objectives: Tricuspid regurgitation is a pathology that usually occurs secondary to left heart pathologies and affects the daily activities of the patients. The long-term results of tricuspid valve replacement are not very encouraging. Therefore, the primary treatment for tricuspid valve regurgitation is repair. Therefore, which repair method should be used is very critical. The aim of our study is to compare tricuspid valve De Vega annuloplasty (TDVA) and tricuspid valve ring annuloplasty (TRA) methods, which are frequently used in tricuspid regurgitation (TR). Methods: Patients who underwent TDVA or TRA in addition to mitral valve replacement at our hospital between January 01, 2017, and December 31, 2019 were included in the study. The study was designed retrospectively and was based on hospital database, patient files, and archive records. A total of 125 patients were included in the study. The pre-operative, intraoperative, and post-operative clinical features of the patients were investigated, and their cardiac status at the last follow-up visit to the hospital was investigated. Results: In the early post-operative and mid-term evaluation, TR was similar in both groups. Conclusion: There is no difference between TRA and TDVA techniques in terms of the recurrence of tricuspid valve insufficiency in the early and mid-term post-operative period. Both techniques are not perfect, and there is a need for the development of new strategies and techniques.
- 1 December 2024
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 27 (3) , 119-125
Open AccessA Comparison of Early and Medium-term Results of De Vega Annuloplasty and Ring Annuloplasty Techniques for the Tricuspid Valve Repair in Patients Undergoing Mitral Valve Replacement
Objectives: Tricuspid regurgitation is a pathology that usually occurs secondary to left heart pathologies and affects the daily activities of the patients. The long-term results of tricuspid valve replacement are not very encouraging. Therefore, the primary treatment for tricuspid valve regurgitation is repair. Therefore, which repair method should be used is very critical. The aim of our study is to compare tricuspid valve De Vega annuloplasty (TDVA) and tricuspid valve ring annuloplasty (TRA) methods, which are frequently used in tricuspid regurgitation (TR). Methods: Patients who underwent TDVA or TRA in addition to mitral valve replacement at our hospital between January 01, 2017, and December 31, 2019 were included in the study. The study was designed retrospectively and was based on hospital database, patient files, and archive records. A total of 125 patients were included in the study. The pre-operative, intraoperative, and post-operative clinical features of the patients were investigated, and their cardiac status at the last follow-up visit to the hospital was investigated. Results: In the early post-operative and mid-term evaluation, TR was similar in both groups. Conclusion: There is no difference between TRA and TDVA techniques in terms of the recurrence of tricuspid valve insufficiency in the early and mid-term post-operative period. Both techniques are not perfect, and there is a need for the development of new strategies and techniques.
- Open Access
- 1 August 2022
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 32 (3) , 330-334
Open Heart Surgery In Octogenarian Patients: A Comparison Of Two Eras
Aim: In this study, it was aimed to compare two different periods in terms of surgical results in octogenarian patients who underwent open heart surgery. Material and method: In the present study, 218 patients aged 80 and over who had undergone open heart surgery in our clinic between January 2013 and December 2020 (group 1:115 patients) and between January 2000 and December 2007 (group 2:103 patients) were included and divided into two groups. The study was designed retrospectively, and the operative and postoperative data were statistically compared between the two groups. Results: There was no significant difference between groups in terms of mean age and gender distribution (p>0.05). Coronary artery bypass graft-beating heart prevalence in Group 2 (24.5%) was significantly higher than that in Group 1 (7.9%) (p:0.002; p
- 1 August 2022
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 32 (3) , 330-334
Open AccessOpen Heart Surgery In Octogenarian Patients: A Comparison Of Two Eras
Aim: In this study, it was aimed to compare two different periods in terms of surgical results in octogenarian patients who underwent open heart surgery. Material and method: In the present study, 218 patients aged 80 and over who had undergone open heart surgery in our clinic between January 2013 and December 2020 (group 1:115 patients) and between January 2000 and December 2007 (group 2:103 patients) were included and divided into two groups. The study was designed retrospectively, and the operative and postoperative data were statistically compared between the two groups. Results: There was no significant difference between groups in terms of mean age and gender distribution (p>0.05). Coronary artery bypass graft-beating heart prevalence in Group 2 (24.5%) was significantly higher than that in Group 1 (7.9%) (p:0.002; p
- Open Access
- 1 April 2022
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 25 (1) , 1-5
Early and Long Term Results of Our Open Heart Surgical Operations in the Presence of Active Oncological Diseases
Introduction: Active cancer and heart disease, which share similar environmental and biological characteristics, can occur concomitantly. Open heart surgery may be required for these patients when indicated. This study aims to demonstrate the early and long-term results and discuss the intervention strategy in patients with different types of active malignancies, who underwent open-heart surgery. Patients and Methods: Between January 2012 and May 2020, open-heart surgery was performed on 10 patients with active malignancies. The mean age was 65.5 (52-77), and four of the patients were female. Two patients were operated on urgently due to advanced pleural effusion. AVR+CABG, CABG, CABG+left upper lobectomy, and AVR+MVR were performed in four patients with lung cancer; AVR+CABG were performed in one patient with colon cancer; CABG was performed in four patients each with one of the following conditions: lymphoma, breast cancer, essential thrombocytosis, meningioma); and mass resection operation from the left atrium and left ventricle was performed in one patient with osteosarcoma. Results: Eight patients were discharged and two patients died in the early postoperative period. Postoperative left hemiparesis developed in one patient. Six-month, one-year and five-year survival rates were 79%, 37.5% and 25%, respectively. Conclusion: Open-heart surgery can be successfully performed with acceptable mortality and morbidity rates on the high-risk patient group with active cancer.
- 1 April 2022
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 25 (1) , 1-5
Open AccessEarly and Long Term Results of Our Open Heart Surgical Operations in the Presence of Active Oncological Diseases
Introduction: Active cancer and heart disease, which share similar environmental and biological characteristics, can occur concomitantly. Open heart surgery may be required for these patients when indicated. This study aims to demonstrate the early and long-term results and discuss the intervention strategy in patients with different types of active malignancies, who underwent open-heart surgery. Patients and Methods: Between January 2012 and May 2020, open-heart surgery was performed on 10 patients with active malignancies. The mean age was 65.5 (52-77), and four of the patients were female. Two patients were operated on urgently due to advanced pleural effusion. AVR+CABG, CABG, CABG+left upper lobectomy, and AVR+MVR were performed in four patients with lung cancer; AVR+CABG were performed in one patient with colon cancer; CABG was performed in four patients each with one of the following conditions: lymphoma, breast cancer, essential thrombocytosis, meningioma); and mass resection operation from the left atrium and left ventricle was performed in one patient with osteosarcoma. Results: Eight patients were discharged and two patients died in the early postoperative period. Postoperative left hemiparesis developed in one patient. Six-month, one-year and five-year survival rates were 79%, 37.5% and 25%, respectively. Conclusion: Open-heart surgery can be successfully performed with acceptable mortality and morbidity rates on the high-risk patient group with active cancer.
- Open Access
- 1 April 2021
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 24 (1) , 63
Right Coronary Endarterectomy with Stent Removal Before Right Coronary Artery Bypass During Coronary Artery Bypass Grafting Surgery
- 1 April 2021
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 24 (1) , 63
Open AccessRight Coronary Endarterectomy with Stent Removal Before Right Coronary Artery Bypass During Coronary Artery Bypass Grafting Surgery
- Open Access
- 1 December 2020
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 23 (3) , 191-195
Intraaortic Balloon Pump in Open Heart Surgery: Comparisons of the Results Obtained in the Preoperative, Intraoperative and Postoperative Implantations Periods
- 1 December 2020
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 23 (3) , 191-195
Open AccessIntraaortic Balloon Pump in Open Heart Surgery: Comparisons of the Results Obtained in the Preoperative, Intraoperative and Postoperative Implantations Periods
- 11 July 2005
- Published by IMR Press in The Heart Surgery Forum
- Vol. 8 (4) , E280-E283
Operative Mortality after Valvular Reoperations
We're building the foundations of the future - starting right now. Join, learn, and share your knowledge.
- 11 July 2005
- Published by IMR Press in The Heart Surgery Forum
- Vol. 8 (4) , E280-E283
Operative Mortality after Valvular Reoperations
We're building the foundations of the future - starting right now. Join, learn, and share your knowledge.